Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines to ...

Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "Cell Line Characterization and Cell Line Development Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Source of Cell Line / ...

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...

Think about your favorite medicine. Maybe it is a vaccine or a powerful antibody. Have you ever wondered how it is made? It does not come from a chemical plant. It often comes from living cells.

Discover how to streamline your cell line development process for recombinant protein and monoclonal antibody production with this in-depth eBook. Whether you're working with CHO, HEK293, or hybridoma ...

Over the past decade, biologics development has moved from artisanal experimentation to a data-driven, platform-based discipline. Analytical depth has improved. Process integration has matured. Yet ...

New GMP-grade cell lines with outstanding growth profile outperform industry standards and enable rapid growth performance for cell and gene therapies COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica ...

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia293 Stable ...

If you’ve ever had to pause a promising experiment while waiting on titer results, you’re not alone. In many labs, samples come off the bioreactor only to sit in line for ELISA or HPLC - and decisions ...

Biologics and cell therapy programs face increasing pressure to generate high-quality cell lines and physiologically relevant 3D models, faster and with greater reproducibility. Integrated automation ...

BOSTON, March 17, 2026 (GLOBE NEWSWIRE) -- Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a cell line development partnership with Score ...